This company has been marked as potentially delisted and may not be actively trading. Cyanotech (CYAN) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesInsider TradesShort InterestTrendsBuy This Stock CYAN vs. HAPP, BON, SMFL, CSCI, KPRX, POAI, PCSA, DWTX, MTNB, and APREShould you be buying Cyanotech stock or one of its competitors? The main competitors of Cyanotech include Happiness Development Group (HAPP), Bon Natural Life (BON), Smart for Life (SMFL), COSCIENS Biopharma (CSCI), Kiora Pharmaceuticals (KPRX), Predictive Oncology (POAI), Heatwurx (PCSA), Dogwood Therapeutics (DWTX), Matinas Biopharma (MTNB), and Aprea Therapeutics (APRE). Cyanotech vs. Its Competitors Happiness Development Group Bon Natural Life Smart for Life COSCIENS Biopharma Kiora Pharmaceuticals Predictive Oncology Heatwurx Dogwood Therapeutics Matinas Biopharma Aprea Therapeutics Cyanotech (NASDAQ:CYAN) and Happiness Development Group (NASDAQ:HAPP) are both small-cap medicinals & botanicals industry companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends. Which has more risk & volatility, CYAN or HAPP? Cyanotech has a beta of -0.11, indicating that its share price is 111% less volatile than the S&P 500. Comparatively, Happiness Development Group has a beta of 0.23, indicating that its share price is 77% less volatile than the S&P 500. Is CYAN or HAPP more profitable? Happiness Development Group has a net margin of 0.00% compared to Cyanotech's net margin of -19.50%. Happiness Development Group's return on equity of 0.00% beat Cyanotech's return on equity.Company Net Margins Return on Equity Return on Assets Cyanotech-19.50% -44.71% -19.12% Happiness Development Group N/A N/A N/A Which has preferable earnings and valuation, CYAN or HAPP? Cyanotech has higher earnings, but lower revenue than Happiness Development Group. Cyanotech is trading at a lower price-to-earnings ratio than Happiness Development Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCyanotech$23.07M0.09-$5.27M-$0.66-0.44Happiness Development Group$95.59M0.06-$49.19M$0.481.60 Do insiders & institutionals believe in CYAN or HAPP? 24.4% of Cyanotech shares are held by institutional investors. Comparatively, 15.2% of Happiness Development Group shares are held by institutional investors. 29.1% of Cyanotech shares are held by insiders. Comparatively, 15.6% of Happiness Development Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media prefer CYAN or HAPP? In the previous week, Cyanotech's average media sentiment score of 0.00 equaled Happiness Development Group'saverage media sentiment score. Company Overall Sentiment Cyanotech Neutral Happiness Development Group Neutral SummaryHappiness Development Group beats Cyanotech on 7 of the 11 factors compared between the two stocks. Get Cyanotech News Delivered to You Automatically Sign up to receive the latest news and ratings for CYAN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CYAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYAN vs. The Competition Export to ExcelMetricCyanotechMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.09M$3.54B$5.84B$10.14BDividend YieldN/AN/A5.68%4.60%P/E Ratio-0.449.4875.4125.98Price / Sales0.0979.38513.64284.11Price / CashN/A5.6237.5660.44Price / Book0.221.1712.156.29Net Income-$5.27M$17.44M$3.29B$271.07M Cyanotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYANCyanotech0.4488 of 5 stars$0.29-2.5%N/A-60.5%$2.09M$23.07M-0.4495Gap DownHAPPHappiness Development GroupN/A$0.72+3.8%N/A-13.8%$4.98M$95.59M1.49215Gap UpBONBon Natural LifeN/A$1.48+5.0%N/A-95.8%$247K$23.84M0.00100Gap UpSMFLSmart for LifeN/A$0.00+100.0%N/A-100.0%$16K$11.11M0.00110Gap UpCSCICOSCIENS BiopharmaN/A$3.08+1.3%N/A-37.3%$9.65M$9.59M-0.5120Positive NewsKPRXKiora Pharmaceuticals2.6031 of 5 stars$2.73-1.8%$10.00+266.3%-27.9%$9.55M$16.02M-0.9410Short Interest ↑POAIPredictive Oncology0.8597 of 5 stars$0.91+3.7%N/A+5.6%$9.53M$1.62M-0.3030Short Interest ↓PCSAHeatwurx3.6971 of 5 stars$0.19-0.5%$1.00+431.6%-86.3%$9.52MN/A-0.0820Short Interest ↓DWTXDogwood Therapeutics2.1054 of 5 stars$4.89-1.3%$10.00+104.3%N/A$9.48MN/A-0.265Gap DownMTNBMatinas Biopharma0.123 of 5 stars$1.83+0.5%N/AN/A$9.31MN/A-0.3830Short Interest ↑APREAprea Therapeutics2.7702 of 5 stars$1.57+0.3%$15.50+887.3%-51.0%$9.12M$1.50M-0.687Short Interest ↑Gap Down Related Companies and Tools Related Companies HAPP Competitors BON Competitors SMFL Competitors CSCI Competitors KPRX Competitors POAI Competitors PCSA Competitors DWTX Competitors MTNB Competitors APRE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CYAN) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredApple’s falling behindApple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...Porter & Company | SponsoredAmerica’s most terrifying chart?MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored6-Figure Target for BTC by 2025The U.S. just announced it's putting GDP data directly onto Bitcoin and Ethereum blockchains. Could this spa...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyanotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyanotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
